Results 151 to 160 of about 32,682 (238)

The Endocannabinoid System in the Development and Treatment of Obesity: Searching for New Ideas. [PDF]

Int J Mol Sci
Serefko A, Lachowicz-Radulska J, Jach ME, Świąder K, Szopa A.   +4 more
europepmc   +1 more source

Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer's disease-finding from Alzheimer's Disease Neuroimaging Initiative. [PDF]

Alzheimers Res Ther
Borkowski K, Yin C, Kindt A, Liang N, de Lange E, Blach C, Newman JW, Kaddurah-Daouk R, Hankemeier T, Alzheimer’s Disease Neuroimaging Initiative.   +9 more
europepmc   +1 more source

Endocannabinoide [PDF]

, 2017
A. M. Gressner, O. A. Gressner
openaire   +1 more source

Several endocannabinoids and amino acids may be biosynthetically converted to catecholamines <i>in vivo</i>. [PDF]

Front Pharmacol
Fitzgerald PJ.
europepmc   +1 more source

Metabolism of endocannabinoids and related N‐acylethanolamines: Canonical and alternative pathways

The FEBS Journal, 2013
N. Ueda, K. Tsuboi, T. Uyama
semanticscholar   +1 more source

Obesity and Gut-Brain Communication: The Cholinergic-Endocannabinoid Link. [PDF]

J Neurosci
Jones LA, Skoug C.
europepmc   +1 more source

Bridging reward and resilience: the endocannabinoid system as a unifying mechanism in exercise-induced protection against major depressive disorder. [PDF]

Front Psychiatry
Zhang G, Hu Q, Zou H.
europepmc   +1 more source

The Endocannabinoid System in Human Disease: Molecular Signaling, Receptor Pharmacology, and Therapeutic Innovation. [PDF]

Int J Mol Sci
Șerban M, Toader C, Covache-Busuioc RA.
europepmc   +1 more source